Feasibility study of automated telemetic electrodiagnostic system

Assessment of technical/economic feasibility of a telematic
electrodiagnostic system for clinical/research/teaching
purposes with facilities for self-configuration/automated
data analysis/self diagnostics operating at lower costs.

Health care is the largest industry in the European Community (EC) with spending running at 8.5% of Gross National Product. In the U.S. it is 12.3%. The impact of scientific advances on the Health Industry has been to increase its diagnostic and treatment potential by escalating costs resulting in discussions of rationing of treatment. Modern advanced electrodiagnosis, though extremely valuable in diagnosis, prognosis and management of many diseases, is an expensive resource. Modern information technology, electronic engineering and telematics, combined with progress in neurophysiology and neuropharmacology, can reverse the situation by providing the basis for the development of new medical instrumentation. These instruments, once developed, would reduce substantially the costs of equipment and the necessary skills to operate it while providing even higher quality diagnostic and prognostic information compared with what the existing and expertise provides today, without the need for the patient to travel long distances to specialised centres. The aim of the ATELS project is to propose a design for a prototype of a telematic biomedical electrobiological information processing system to be operated by non-specialised technicians and, through telematic links, providing expert medical opinion. Such a system can reduce the cost and time of electrodiagnosis from recording to the final report by 70% and expand the capabilities of electrodiagnosis to young infants, children and uncooperative subjects with neurological and psychiatric diseases. The fields of the system application will be: Electroculography; Electroretinography; Visual evoked and event related potentials; Steady state potentials; Somatosensory evoked and event related potentials; Electromyography; Electroencephalography; Automatic function (ECG, plethysmography, respiration, etc.); Pupillometry; Colour vision testing. It is essential for the development of the ATELS system that it be used by clinicians in areas remote from the site of its development and the envisaged facilities of the system are to be tested in a real clinical environment by personnel with a limited insight into the technology of the system. The EUREKA partnership makes possible the extensive validation trials at the INSTITUTE OF OPHTHAMOLOGY, Athens, GREECE, which provides an ideal testing ground. It will then be possible via the EUREKA partnership to establish standardised stimulus presentation and recording procedures thus creating a foundation for the regularly upgradable European normative data base upon which the decisions for the normality of individual patients rest. For the individual user this will bring enormous savings in cost and time, together with enhanced confidence in the evaluation of results. In short, the ATELS system will provide modern bioelectrical electrodiagnosis in any Medical/Research centre all over the world at low cost and with high reliability.
Project ID: 
1 026
Start date: 
Project Duration: 
Project costs: 
1 490 000.00€
Technological Area: 
Market Area: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.